Activities, Bill Numbers and Titles
|
|
Client: Pharmaceutical Research and Manufacturers of America, Inc.
|
|
Senate Bill
|
721
|
An Act relative to mandatory prescription drug coverage
|
Oppose
|
$65.15
|
N/A
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$677.51
|
N/A
|
Senate Bill
|
673
|
An Act protecting Massachusetts hospitals and health systems
|
Oppose
|
$521.16
|
N/A
|
Senate Bill
|
703
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$65.15
|
N/A
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$8,468.85
|
N/A
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$677.51
|
N/A
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$130.29
|
N/A
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$677.51
|
N/A
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Oppose
|
$677.50
|
N/A
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$8,468.85
|
N/A
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$677.51
|
N/A
|
| | |
Total amount
|
$21,106.99
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|